NanoString Technologies Inc. (NSDQ:NSTG) has announced a spatial molecular imaging platform for multiplexed analysis of RNA and protein expression for individual cells within intact tissue samples.  The spatial molecular imaging (SMI) platform supports tissue samples of Formalin-fixed paraffin-embedded and fresh-frozen specimens as well as organoids.  The SMI platform is designed to complement the company’s GeoMx…